Background and Objectives: Recently a rapid decrease in the susceptibility of Neisseria gonorrhoeae isolates to fluoroquinolones has occurred and gonococcal fluoroquinolone resistance is now a significant problem in the treatment of gonorrhoea in Japan. Thus, in order to investigate the quinolone resistance mechanisms in clinical isolates of Ngonorrhoeae we studied an alteration in the DNA gyrase subunit A (GyrA) which is well-known as a common mechanism of bacterial quinolone resistance.
Introduction
Fluoroquinolones such as norfloxacin, ofloxacin, and ciprofloxacin exert excellent in vitro antimicrobial activity against Neisseria gonorrhoeae, including penicillin-and tetracycline-resistant strains. Fluoroquinolones have proven to be highly effective as oral singledose treatment for gonococcal infections. Thus, in the past decade, fluoroquinolone regimens have been used increasingly in developed countries for therapy of gonorrhoea, as well as genitourinary tract infections and other bacterial infections. However, the emergence of gonococcal isolates showing reduced susceptibility to fluoroquinolones has recently been reported in several countries.'-7 In Japan, gonococcal fluoroquinolone resistance is now a significant problem in the treatment of gonorrhea.89 It is therefore important to study quinolone resistance mechanisms in clinical isolates of Ngonorrhoeae.
In several bacterial species such as Escherichia coli and Staphylococcus aureus, two main mechanisms by which the bacteria acquire resistance to fluoroquinolones have been proposed. First, mutations in DNA gyrase subunit A (GyrA) and subunit B (GyrB) genes of the target DNA gyrase proteins lead to lower inhibitory activities of fluoroquinolones against DNA gyrase. In E coli, mutation at serine-83 in the GyrA is most commonly found in quinolone-resistant strains.'01' Second, an alteration in drug permeation is also known to be a role of resistance to quinolones. In E coli, this phenomenon has been associated with mutations leading to decreasing amounts of the outer membrane protein OmpF." 12-1 Furthermore, an active efflux system has recently been reported as the quinolone resistance mechanism in gram-negative bacteria." However, less is known about quinolone resistance mechanisms in gonococci. "'6 7 Our previous investigation'6 demonstrated that an alteration in drug permeability was associated with quinolone resistance in 2 of 4 Extraction of DNA and synthesis of oligonucleotides Chromosomal DNA was extracted by the rapid boiling method described previously'8 and subjected to polymerase chain reaction (PCR). To amplify a DNA fragment of the GyrA gene corresponding to amino acids positions 53 to 179, which includes the region of N gonorrhoeae GyrA termed "the quinolone resistance-determining region" corresponding to amino acids positions 55 to 110 of gonococcal GyrA,"7 two oligonucleotides (NGGYRA Fl, 5'-TGCACCGGCGCGTACTGTAC-3'; NGGYRA RI, 5'-ACGAGCCGTTGAC-GAGCAGT-3') which were purchased from Takara Shuzo Co Ltd Biochemical Group (Shiga, Japan) were used. These primers were located within consensus amino acids of the bacterial GyrA proteins, and yielded a product of 384 bp DNA fragment after PCR amplification.
PCR
PCR amplification was performed in 20 ul of a reaction mixture containing 5 pmol each of the two primers, 20 nmol each of the four deoxynucleotide triphosphates, 10 mM Tris- Direct DNA sequencing PCR-amplified DNA was sequenced with synthetic oligonucleotide primer (NGGYRA Fl or NGGYRA R1) by the dideoxy-chain termination method,'9 using the BcaBEST dideoxy sequencing kit dCTP version (Takara, Japan) and [a-35S] dCTP (Amersham, UK). The samples were electrophoresed in 5% Long Ranger Gel (AT Biochem, USA) containing 7M urea at 1800 V. The gel was dried and exposed to x ray film (Fuji Photo Film, Japan).
Results
The antimicrobial susceptibilities of the nine gonococcal strains to norfloxacin, ofloxacin, ciprofloxacin, penicillinG, ceftriaxone, tetracycline, and spectinomycin are summarised in table 1. All of the nine strains were negative for ,B-lactamase production. The isolates A-10 (MIC; 8'0 ,g/ml) and A-22 (MIC; 4 0,ug/ml) were highly resistant to norfloxacin and A-55 (MIC; 1.0 0g/ml) and A-161 (MIC; 2-0 ,g/ml) were moderately resistant to norfloxacin. The strains A-37, A-69, WHO-A, WHO-B, and WHO-D were susceptible to norfloxacin, for which MICs of norfloxacin were 0.063, 0.004, 0.004, 0.031, and 0.063 ,g/ml, respectively. The four norfloxacinresistant isolates showed 16-to 2000-fold higher MIC values of the antibiotic, as compared with those of the 5 norfloxacin-susceptible strains, and were cross-resistant to ofloxacin and ciprofloxacin. Furthermore, the high-level norfloxacin-resistant isolates (A-10 and A-22) showed less susceptibilities to penicillin, ceftriaxone, and tetracycline than did the norfloxacin-susceptible isolates (A-37 and A-69).
In the previous study,'6 to research the other quinolone resistance mechanism of alteration in drug permeability in gonococci, we measured intracellular accumulation of norfloxacin in the same six clinical and three WHO strains tested in the present investigation. Among the four norfloxacin-resistant iso- tData from reference 16. 
